Phaos Technology Holdings (Cayman) (POAS) Current Leases (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) reported Current Leases of $40368.0 for Q4 2025, down 50.56% quarter-over-quarter from $81649.5 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Current Leases (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) has reported Current Leases for 2 years, with the latest figure at $40368.0 in Q4 2025.

For the quarter ending Q4 2025, Current Leases changed N/A year-over-year to $40368.0; the trailing twelve-month figure through Oct 2025 stood at $40368.0 (changed N/A YoY), and the FY2025 full-year result was $81724.3, down 17.11% from the prior year.
Current Leases for Q4 2025 stood at $40368.0, down from $81649.5 in the prior quarter.
The five-year high for Current Leases was $98591.3 in Q2 2024, with the low at $40368.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	24.30 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	20.50 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	35.80 Mn
10	Phaos Technology Holdings (Cayman)	682,234.12	627,245.12	-	40,368.00

Download Data